Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
Spriet
Isabel
I
Meersseman
Philippe
P
Meersseman
Wouter
W
de Hoon
Jan
J
Willems
Ludo
L
D000284:Administration, Oral; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001228:Aspergillosis / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004347:Drug Interactions; D005260:Female; D006801:Humans; D010672:Phenytoin / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D014230:Triazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D065819:Voriconazole
D000927:Anticonvulsants; D000935:Antifungal Agents; D004338:Drug Combinations; D011743:Pyrimidines; D014230:Triazoles; D010672:Phenytoin; D065819:Voriconazole